Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
249K
-
Shares change
-
+7.42K
-
Total reported value, excl. options
-
$488K
-
Value change
-
+$3K
-
Number of buys
-
5
-
Number of sells
-
-4
-
Price
-
$1.96
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q3 2019
15 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q3 2019.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 249K shares
of 129M outstanding shares and own 0.19% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (121K shares), GEODE CAPITAL MANAGEMENT, LLC (89.9K shares), Federation des caisses Desjardins du Quebec (13K shares), NORTHERN TRUST CORP (12.5K shares), JPMORGAN CHASE & CO (11.4K shares), Ahrens Investment Partners LLC (10K shares), VICTORY CAPITAL MANAGEMENT INC (1.64K shares), UBS Group AG (1.41K shares), BlackRock Inc. (615 shares), and GROUP ONE TRADING, L.P. (500 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.